Adenosine A2a Receptor antibody (C-Term, Cytoplasmic Domain)
Quick Overview for Adenosine A2a Receptor antibody (C-Term, Cytoplasmic Domain) (ABIN1731565)
Target
See all Adenosine A2a Receptor (ADORA2A) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term, Cytoplasmic Domain
-
Specificity
- Reacts with human ADORA2A
-
Purification
- Antigen affinity purified
-
Immunogen
- Synthetic 20 amino acid peptide from C-terminal cytoplasmic domain of human ADORA2A. Percent identity with other species by BLAST analysis: Human (100%), Gorilla, Gibbon, Monkey, Marmoset (95%), Dog (80%).
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
IHC - P (10 μg/mL) -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-80 °C
-
Storage Comment
- Long term: -70°C, Short term: +4°C
-
-
- Adenosine A2a Receptor (ADORA2A)
-
Alternative Name
- ADORA2A
-
Background
- Receptor for adenosine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.
-
Gene ID
- 135
-
Pathways
- Neurotrophin Signaling Pathway, cAMP Metabolic Process, Synaptic Membrane, Feeding Behaviour, Cancer Immune Checkpoints
Target
-